President & CEO
Erica Rogers is the President and CEO of Silk Road Medical. Prior to Silk Road Medical, Erica was the COO of Medicines360, a non-profit pharmaceutical company developing drugs and devices for women. Erica was the founder and CEO of Allux Medical, as well as the co-founder of Visiogen, which was acquired by Abbott Medical Optics in 2009. Erica spent over 12 years at Boston Scientific, in sales and marketing positions. She began her career in pharmaceutical sales after receiving a B.S. in zoology from San Diego State University. Erica holds five issued and 15 pending US patents in medical devices and nanotechnology.
Chief Medical Officer
Sumaira Macdonald, MD, PhD is the Chief Medical Officer at Silk Road Medical. Prior to joining Silk Road Medical Inc., Dr. Macdonald was a Vascular Radiologist and Honorary Clinical Senior Lecturer at Newcastle University and the Freeman Hospital, Newcastle upon Tyne, UK. Dr. Macdonald is well regarded for her career-long efforts to improve endovascular interventions. In addition to being the Co-Editor of the Springer “Carotid Stenting; A Practical Guide”, Dr. Macdonald has authored over 70 medical publications on vascular disease, is the recipient of many academic society honors, serves on the editorial boards of a number of scientific journals and is highly sought after as a speaker, having given over 300 international lectures.
Chief Technology Officer & VP of Operations
Mike Wallace is the Chief Technology Officer and Vice President of Operations at Silk Road Medical and has a proven track record of bringing new, pioneering products and procedures to the market during his 20 years in the Medical device space. Prior to joining Silk Road Medical, Mike held executive leadership roles as the VP of R&D at Boston Scientific with 1 year in Electrophysiology & 10 years in the Neurovascular Division, Executive VP of R&D and Operations at start-up Baxano (acquired by Trans1) and VP of R&D for start-up Barrx Medical (acquired by Covidien). Mike obtained his B.S. & M.S. in Mechanical Engineering with emphasis in Bioengineering from University of Delaware and University of California, Davis, respectively. Mike has over 120 issued or pending US patent applications and several scientific publications.
Executive VP of Clinical, & Regulatory Affairs, and Quality Assurance
Ric Ruedy joined Silk Road in 2011 and is the Executive Vice President of Clinical and Regulatory Affairs, and Quality Assurance. Ric brings to Silk Road Medical 25 years of experience in the Regulatory, Clinical and Quality areas for both multi-national corporations and venture-backed start-ups. Prior to Silk Road Medical, Ric served as Vice President of Regulatory, Clinical and Quality for Nevro Corporation and, earlier, at Cardica, Inc. Ric also served as Director of Regulatory Affairs at Abbott Vascular, where he obtained the second carotid stent approval in the United States. Ric is a co-founder of Acta Vascular (acquired by Covidien) and held positions of increasing responsibility at Edwards Lifescienses, Medtronic, TriPath Imaging (acquired by Becton Dickinson), and Parallax Medical (acquired by Arthrocare). Ric has a B.A. in English and International Relations from Bucknell University.
Executive VP of Corporate Development and Commercialization
Lucas Buchanan leads strategy, marketing, business development, and reimbursement efforts for Silk Road Medical. Prior to joining the company full time, Lucas was an investment professional with The Vertical Group, the founding investor in Silk Road, where he led investments in Atheromed (acquired by Volcano Corporation) and Lutonix (acquired by CR Bard). Lucas has held various leadership positions in marketing and corporate development/M&A at Impax Laboratories, Medtronic, and Ernst & Young. Lucas holds a B.A. in Economics from Duke University and an M.B.A. in Health Care Management from The Wharton School at the University of Pennsylvania.
Executive VP of Global Sales
Andrew Davis joined Silk Road Medical in May of 2015 and is the Executive Vice President of Global Sales. Andrew brings to Silk Road Medical over 20 years of experience in the medical device field with deep expertise in launching innovative, minimally invasive therapies that increase patient access and solve unmet clinical needs in cardiovascular diseases. Prior to joining Silk Road Medical, Andrew was the Vice President of Sales and Marketing at Acelity’s Advanced Wound Therapy Group. Prior to Acelity, he spent 15yrs at Medtronic and held Vice President of Sales positions for Structural Heart CoreValve, Endovascular AAA/TAA, Peripheral and Spinal/Biologics divisions. Andrew began his career in pharmaceutical sales at Johnson and Johnson after receiving a B.S. in Political Science from Florida State University.
Vice President of Finance & Administration
Mark Caires is the Vice President of Finance & Administration at Silk Road Medical. Mark brings with him over 20 years of financial expertise in small and start-up companies. Prior to Silk Road Medical, Mark was the Senior Director of Finance and Administration at Broncus Technologies, Inc. Mark received his B.S. in Mathematics and Economics from Santa Clara University in 1987 and his M.B.A in Finance from San Diego State University.